KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Continuing Operations (2016 - 2025)

Edwards Lifesciences has reported Income from Continuing Operations over the past 17 years, most recently at 64200000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 64200000.0 for Q4 2025, down 81.39% from a year ago — trailing twelve months through Dec 2025 was 1056000000.0 (down 24.36% YoY), and the annual figure for FY2025 was 1056000000.0, down 24.36%.
  • Income from Continuing Operations for Q4 2025 was 64200000.0 at Edwards Lifesciences, down from 292300000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for EW hit a ceiling of 489500000.0 in Q2 2021 and a floor of 64200000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 5 years was 339150000.0 (2021), compared with a mean of 327090000.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 501.56% in 2021 and later plummeted 81.39% in 2025.
  • Edwards Lifesciences' Income from Continuing Operations stood at 335300000.0 in 2021, then tumbled by 40.2% to 200500000.0 in 2022, then soared by 66.13% to 333100000.0 in 2023, then increased by 3.57% to 345000000.0 in 2024, then plummeted by 81.39% to 64200000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 64200000.0 (Q4 2025), 292300000.0 (Q3 2025), and 335900000.0 (Q2 2025) per Business Quant data.